{"ORPHApacket":[{"ORPHApacketID":"2128","date":"2019-12-06 02:07:04","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"2128","Name":[{"lang":"en","label":"Isolated hemihyperplasia"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_2128","DisorderType":[{"Name":[{"lang":"en","label":"Morphological anomaly"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377791"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Overgrowth syndrome"}],"ORPHA":"93460","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_93460"},{"Name":[{"lang":"en","label":"Polymalformative genetic syndrome with increased risk of developing cancer"}],"ORPHA":"183422","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_183422"},{"Name":[{"lang":"en","label":"Macroglossia"}],"ORPHA":"156207","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_156207"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Isolated hemihyperplasia is a rare overgrowth syndrome characterized by an asymmetric regional body overgrowth, involving at least one limb, and associated with an increased risk of developing embryonal tumors, principally nephroblastoma (see this term) and hepoblastoma."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"235000","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Hemi 3 syndrome"},{"lang":"en","label":"Hemicorporal hypertrophy"},{"lang":"en","label":"Isolated hemihypertrophy"}]}],"HPODisorderAssociationList":[{"count":"12","HPODisorderAssociation":[{"HPOId":"HP:0000023","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000023","HPOTerm":"Inguinal hernia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000028","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000028","HPOTerm":"Cryptorchidism","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000164","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000164","HPOTerm":"Abnormality of the dentition","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0000324","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000324","HPOTerm":"Facial asymmetry","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001256","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001256","HPOTerm":"Intellectual disability, mild","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001528","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001528","HPOTerm":"Hemihypertrophy","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0001555","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001555","HPOTerm":"Asymmetry of the thorax","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002475","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002475","HPOTerm":"Myelomeningocele","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002564","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002564","HPOTerm":"Malformation of the heart and great vessels","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002650","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002650","HPOTerm":"Scoliosis","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002667","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002667","HPOTerm":"Nephroblastoma","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0007328","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0007328","HPOTerm":"Impaired pain sensation","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}